DAFTAR PUSTAKA

Antman, EM, Braunwald, E 1997, Acute myocardial infarction

in: E. Braunwald (ed) Heart Disease, A Textbook of
Cardiovascular Medicine, 5th edition, W.B. Saunders
Company, pp. 1233-1241.

Arsenault, BJ, Lemieuc, I, Despres, JP, et al. 2007,

'Cholesterol levels in small LDL particles predict the
risk of coronary heart disease in the EPIC-Norfolk
prospective population study', European Heart Journal,
vol 28, pp: 2770-2777

Bassand, JP, Hamm, CW, Ardissino, D, et al. 2007,

'Guidelines for the diagnosis and treatment of non-ST-
segment elevation acute coronary syndromes', European
Heart Journal, vol. 28, no. 13, pp. 1598–660.

Berliner, JA, Navab, M, Fogelman, AM, et al. 1995,

,'Atherosclerosis: basic mechanisms. oxidation,
inflammation, and genetics', Circulation, vol. 91, pp.
2488-2496.

Carmena, R, Duriez, P, & Fruchart, JC 2004, 'Atherogenic

lipoprotein particles in atherosclerosis', Circulation,
vol. 109, no. 23, pp. III2–I7.

Dahlan, MS 2010, Besar sampel dan cara pengambilan sampel

dalam Penelitian Kedokteran dan Kesehatan, 3edn, Salemba
Medika, Jakarta.

DeMaria, A, Blanchard, D 1998, The echocardiogram in Wayne

Alexander R. (ed) Hurst's the heart, 9ed, pp. 415-519,
McGraw-Hill, New York.

El-Menyar, A, Zubaid, M, AlMahmeed, W, Sulaiman, K, AlNabti,

A, Singh, R et al. 2012, 'Killip classification in
patient with acute coronary syndrome: insight from
multicenter registry', American Journal of Emergency
Medicine, vol. 30, pp:97-103.

Fox, KF, Cowie, MR, Wood, DA, et al. 2001, 'Coronary artery
disease as the cause of incident heart failure in the
population',European Heart Journal, vol. 22, pp. 228–
236.

Fuster, V, Badimon, L, Badimon, J, & Chesebro, J 1992, 'the

Pathogenesis of coronary artery disease and the acute

86
 coronary syndromes', The New England Journal of
Medicine, vol. 326, no.5, pp. 310-318.

Gharini, PPR, Maharani, E, Setianto, BY 2013, 'Hubungan

kadar soluble CD40 ligand dengan gagal jantung akut pada
pasien infark miokard akut', Bagian Kardiologi dan
Kedokteran Vaskular Fakultas Kedokteran UGM.

Go, AS, Mozaffarian, D, Roger, VL, et al. 2014, 'Heart

disease and stroke statistics--2014 update: a report
from the American Heart Association', Circulation, vol.
129, pp. e28–e292.

Gruzdeva, O, Uchasova, E, Dyleva, Y, Belik, E, Kashtalap, V

dan Barbarash, O 2013, 'Relationship between free fatty
acids, insulin resistance markers, and oxidized
lipoprotein in myocardial infarction and acute left
ventricular failure', Dove Medical Press, vol. 6, pp:
333-56.

Grundy, SM, Cleeman, JI, Merz, CN 2004, 'Implication of

recent clinical trials for the national cholesterol
education program adult treatment panel III guidelines',
Circulation, vol. 110, no. 2, pp: 227-39.

Hadipurnomo, S, Setianto, BY, Dinarti, LK 2011, Hubungan

kadar serum Matrix Metalloproteinase-9 terhadap kejadian
gagal jantung akut sebagai komplikasi sindroma koroner
akut, Fakultas Kedokteran Universitas Gadjah Mada.

Hamm, CW, Bassand, JP, Agewall, S, et al. 2011, 'ESC

Guidelines for the management of acute coronary
syndromes in patients presenting without persistent ST-
segment elevation: The Task Force for the management of
acute coronary syndromes (ACS) in patients presenting
without persistent ST-segment elevatio', European Heart
Journal, vol. 32, no. 23, pp. 2999–3054.

Hasdai, D, Topol, EJ, Kilaru, R, et al. 2003, 'Frequency,

patient characteristics, and outcomes of mild-to-
moderate heart failure complicating ST-segment elevation
acute myocardial infarction: lessons from 4
international fibrinolytic therapy trials', American
Heart Journal, vol. 145, pp. 73-79.

Hirano, T, Itom, Y, Koba, S, Toyoda, M, Ikejiri, A 2004, '

Clinical significance of small dense low-density
lipoprotein cholesterol levels determined by the simple
precipitation method’, Arterioscler Thromb Vasc Biol,
vol. 24, no. 3, pp. 558-63.

87
Killip, T, Kimball, JT 1967, 'Treatment of myocardial
infarction in a coronary care unit. a two year
experience with 250 patients', American Journal
Cardiology, vol. 20, pp. 457-64.

Kleinschmidt, KC 2006, 'Epidemiology and pathophysiology of

acute coronary syndrome', Johns Hopkins Advanced Studies
in Medicine, vol. 6, pp. 477–82.

Koba, S, Yokota, Y, Hirano, T, et al. 2008, 'Small ldl-

cholesterol for determining severe coronary
atherosclerosis', Journal of Atherosclerosis and
Thrombosis, vol. 15, no. 5, pp.250-260.

Konstam, MA, Kramer, DG, Patel, AR, Maron, MS, Udelson, JE

2011, 'Left ventricular remodelling in heart failure:
current concepts in clinincal significance and
assessment', Journal of American College of Cardiology,
vol.4, no.1, pp: 98-108.

Kumar, A, & Cannon, CP 2009, 'Acute coronary syndromes:

diagnosis and management', Mayo Clinic Proceedings, Part
I, vol. 84(October), pp. 917–38.

Kwiterovich, POJ 2002, 'Lipoprotein heterogeneity:

diagnostic and therapeutic implications', American
Journal of Cardiology, vol. 90, no. 8, pp. 1–10.

Kwon, SW, Yoon, SJ, Kang, TS 2006, 'Significance of small

dense low-density lipoprotein as a risk factor for
coronary artery disease and acute coronary syndrome',
Yonsei Medical Journal, vol.47, no.3, pp: 405-414.

Lamarche, B, Tchernof, A, Moorjani, S, et al. 1997, 'Small,

dense low-density lipoprotein particles as a predictor
of the risk of ischemic heart disease in men:
prospective results from the que´bec cardiovascular
study', Circulation ,vol. 95, no. 1, pp. 69–75.

Lee, M, Saver, JL, Hong, KS, et al. 2012, 'Effect of pre-

diabetes on future risk of stroke: meta-analysis',
British Medical Journal, vol. 344, pp: 3564

Levine, B, & Levine, AB 2013, 'Lipids , atherogenic

dyslipidemia , and therapy', Metabolic Syndrome and
Cardiovascular Disease, 2nd ed., pp. 347–408, Blackwell
Publishing Ltd.

Mahley, RW, Innerarite, TL, Rall, SC, dan Weisgraber, KH

1984, 'Plasma lipoproteins: apolipoprotein structure and

88
 function;, The Journal of Lipid Research, vol. 25, pp:
1277-1294.

Mahmood, SS, Levy, D, Vasan, RS, & Wang, TJ 2014, 'the

Framingham heart study and the epidemiology of
cardiovascular diseases: a historical
perspective',Lancet, vol. 383, no. 9921, pp. 999-1008.

McCullough, PA, Philbin, EF, Spertus, JA, et al. 2002,

'Confirmation of a heart failure epidemic: findings from
the resource utilization among congestive heart failure
(REACH) study', Journal of the American College of
Cardiology, vol. 39, no.1, pp.60-69.

Mihardja, L, & Siswoyo, H 2009, 'Prevalensi dan Faktor

Determinan Penyakit Jantung di Indonesia', Buletin
Penelitian Kesehatan, vol. 37, no. 3, pp. 142-59.

Mohan, V, Deepa, R, Velmurugan, K, & Gokulakrishnan, K 2005,

'Association of small dense LDL with coronary artery
disease and diabetes in urban asian indians', The
Chennai Urban Rural Epidemiology Study ( CURES-8 ), pp.
95–100.

Mudd, JO, Borlaug, BA, Johnston, PV, et al. 2007, 'Defining

the role of low-density lipoprotein heterogeneity in
coronary artery disease', Journal of the American
College of Cardiology, vol. 50. no. 18, pp. 1735–41.

National Cholesterol Education Program (NCEP) 2012, ‘Expert

panel on detection, evaluation, and treatment of high
blood cholesterol in adults (adult treatment panel
III). third report of the national cholesterol
education program (NCEP) expert panel on detection,
evaluation, and treatment of high blood cholesterol
in adults (adult treatment panel III) final report’,
Circulation, vol. 106, no. 25, pp. 3143–421.

Neskovic, AN, Otasevic, P, Bojic, M, et al. 1999,

'Association of Killip class on admission and left
ventricular dilatation after myocardial infarction: a
closer look into an old clinical classification',
American Heart Journal, vol. 137, pp: 361-367.

Nieminen, MS, Böhm, M, Cowie, M, et al. 2005, 'Executive

summary of the guidelines on the diagnosis and treatment
of acute heart failure: the task force on acute heart
failure of the european society of cardiology', European
Heart Journal, vol. 26, no. 4, pp. 384–416.

89
Otvos, JD, Jeyarajah, EJ, & Cromwell, WC 2002, 'Measurement
issues related to lipoprotein heterogeneity', American
Journal of Cardiology, vol. 90, no. 8, pp. 22–29.

Packard, CJ 2003. 'Triacylglycerol-rich lipoproteins and the

generation of small, dense low-density lipoprotein',
Biochemical Society Transactions, vol. 31(Pt 5), pp.
1066–9.

Palazhy, S, Kamath, P, & Vasudevan, DM 2014, 'Estimation of

small , dense LDL particles using equations derived from
routine lipid parameters as surrogate markers',
Biochemistry & Analytical Biochemistry, vol. 3, no.1,
pp. 1–5.

Pfeffer, MA, & Braunwald, E 1990, 'Ventricular remodeling

after myocardial infarction. Experimental observations
and clinical implications'. Circulation, vol. 81, no. 4,
pp. 1161–1172.

Rhee, JW, Sabatine, MS, & Lilly, LS 2011, Acute coronary

syndromes In L. S. Lilly (Ed.), Pathophysiology of Heart
Disease, 5th ed., pp. 161–189. Lippincott WIlliams &
Wilkins.

Richards, AM, Nicholls, MG, Troughton, RW 2002, 'Antecendent

hypertension and heart failure after myocardial
infarction', Journal of the American College of
Cardiology, vol. 39, no. 7, pp. 1182-1188.

Rizzo, M, & Berneis, K 2006, 'Low-density lipoprotein size

and cardiovascular risk assessment', QJM: Monthly
Journal of the Association of Physicians,vol. 99, no. 1,
pp. 1–14.

Roger, VL 2013, 'Epidemiology of heart failure', Circulation

Research, vol. 113 no. 6, pp. 646–659.

Savic, L, Mrdovic, I, Perunicic, J, et al. 2010, 'Prognostic

significance of the occurrence of acute heart failure
after successful primary percutaneous coronary
intervention', Journal of Invasive Cardiology, vol. 22,
no. 7, pp. 307-311.

Sharma, SB, & Garg, S 2012, 'Small dense ldl: risk factor
for coronary artery disease (cad) and its therapeutic
modulation', Indian Journal of Biochemistry &
Biophysics, vol.49, pp. 77-85.

90
Shishehbor, MH, Bhatt, DL 2004, 'Inflammation and
atherosclerosis', Current Atherosclerosis Report, vol.
6, pp. 131-139

Srisawasdi, P, Chaloeysup, S, Teerajetgul, Y, et al. 2011.

'Estimation of plasma small dense LDL cholesterol from
classic lipid measures', American Journal of Clinical
Pathology, vol. 136, no. 1, pp. 20–29.

Steg, PG, Dabbous, OH, Feldman, LJ 2004, 'Determinants and

prognostic impact of heart failure complicating acute
coronary syndromes: observations from the global
registry of acute coronary events (GRACE)', Circulation,
vol. 109, no.4, pp. 494-499.

St-Pierre, AC, Cantin, B, Dagenais, GR, et al. 2004, 'Low-

density lipoprotein subfractions and the long-term risk
of ischemic heart disease in men: 13-year follow up data
from the Quebec cardiovascular study', Journal of the
American Heart Association, pp. 554-559.

Strom, JB, & Libby, P 2011, Atherosclerosis in LS Lilly

(Ed.), Pathophysiology of Heart Disease, 5th ed., pp.
113–134. Lippincott Williams & Wilkins.

Vasan, RS 2003, 'Diastolic Heart Failure', British Medical

Journal, vol. 327, pp.1181-2

Walldius, G, & Jungner, I 2004, 'Apolipoprotein B and

apolipoprotein A-I: risk indicators of coronary heart
disease and targets for lipid-modifying therapy',
Journal of Internal Medicine, vol. 255, no. 2, pp. 188–
205.

Walldius, G, & Jungner, I 2006, 'The apoB/apoA-I ratio: a

strong, new risk factor for cardiovascular disease and a
target for lipid-lowering therapy--a review of the
evidence', Journal of Internal Medicine, vol. 259, no.
5, pp. 493–519.

Wong, M, Staszewsky, L, dan Latini, R 2004,'Severity of left

ventricular remodelling defines outcomes and response
to therapy in heart failure: Valsartan heart failure
trial (Val-HeFT) echocardiographic data', Journal of
the American College of Cardiology

Yancy, CW, Jessup, M, Bozkurt, B, et al. 2013, '2013

ACCF/AHA guideline for the management of heart failure:
a report of the American College of Cardiology
Foundation/American Heart Association Task Force on

91
practice guidelines', Circulation, vol. 128, no. 16, pp.
240–327.

92